Skip to search formSkip to main contentSkip to account menu

PCCG-13

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Evidence that phospholipase D activation prevents group I mGluR-induced persistent prolongation of epileptiform bursts.
Selective activation of group I metabotropic glutamate receptors (mGluRs) with (S)-3,5-dihydroxyphenylglycine (DHPG) in guinea… 
2004
2004
C 91 Glutamate-enhanced muscle spindle excitability-inhibition by PLD-coupled metabotropic glutamate receptor antagonists
50nm, clear synaptic-like vesicles (SLVs) are abundant in primary afferent mechanosensory endings. In muscle spindle primary… 
2001
2001
Metabotropic Glutamate Receptors Stimulate Phospholipase D via Different Pathways in the Adult and Neonate Rat Hippocampus
In order to characterize the ontogenetic profile of metabotropic glutamate (mGlu) receptors coupled to phospholipase D (PLD) we… 
1999
1999
(2R,1'S,2'R,3'S)-2-(2'-Carboxy-3'-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of phospholipase D-coupled metabotropic glutamate receptors: asymmetric…
The asymmetric synthesis of (2R,1'S,2'R, 3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine (PCCG-13), a trisubstituted… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)